Tag: global pharmaceutical firm
-
Indivior to Delist from LSE, Focus on US Market
Indivior, a global pharmaceutical firm specializing in opioid addiction treatment, has decided to delist from the London Stock Exchange (LSE) and focus solely…
Indivior, a global pharmaceutical firm specializing in opioid addiction treatment, has decided to delist from the London Stock Exchange (LSE) and focus solely…